frontiermeds.com valid
Automatically discovered from public files. Ownership management is optional. Inclusion does not imply endorsement or publisher participation.
Manage this listing — optional · Visit publisher ↗
Verify with your agent
Paste this into your coding agent and it claims the listing for you. Verified sites are listed by name in our llms-full.txt, the file agents read, and get a private dashboard for listing controls, file health, measured activity and score history.
Claim my listing on Agent Web Map for frontiermeds.com:
1. POST https://agentwebmap.com/v1/sites/frontiermeds.com/claims and keep claim_id and claim_secret private.
2. Publish the proof: add the line "AgentWebMap ownership: <token>" (token from step 1) to https://frontiermeds.com/llms.txt, or use the DNS, meta-tag or well-known method the response describes.
3. POST https://agentwebmap.com/v1/sites/frontiermeds.com/verify with {"claim_id": "...", "claim_secret": "..."}.
4. Save the api_key from the answer; it manages the listing (PATCH https://agentwebmap.com/v1/sites/frontiermeds.com).
MCP equivalent: tools begin_ownership_claim, then verify_domain, at https://agentwebmap.com/mcp. Docs: https://agentwebmap.com/docs#verifyCorrections or removal requests: contact the directory. Ownership management is optional.
Frontier Medicines
Generated by All in One SEO v5.0.2.1, this is an llms.txt file, used by LLMs to index the site.
Their llms.txt
The beginning of the file, from our validated copy saved 2026-10-21T23:40:39.544Z. Cached copy · Source on frontiermeds.com
# Frontier Medicines
> Generated by All in One SEO v5.0.2.1, this is an llms.txt file, used by LLMs to index the site.
Boldly Advancing Science to Defeat Disease
## Sitemaps
- [XML Sitemap](https://www.frontiermeds.com/sitemap.xml): Contains all public & indexable URLs for this website.
## Posts
- [Frontier Medicines to Present First Clinical Data for FMC-376, an equipotent KRAS G12C ON+OFF Inhibitor, at ESMO Congress 2026](https://www.frontiermeds.com/press-release/frontier-medicines-congress/)
- [Frontier Medicines Strengthens Leadership Team with Appointment of Three Drug Development Veterans](https://www.frontiermeds.com/press-release/frontier-medicines-appoints-veteran-drug-development-leader-david-r-epstein-to-board-of-directors/)
- [Frontier Medicines Appoints Veteran Drug Development Leader David R. Epstein to Board of Directors](https://www.frontiermeds.com/press-release/frontier-medicines-appoints-veteran-drug-development-leader-david-r-epstein-to-board-of-directors-2/)
- [Frontier Medicines Announces Exclusive Licensing Agreement for FMC-220, a First-in-Class Covalent p53 Y220C Activator, with LG Chem, Ltd.](https://www.frontiermeds.com/press-release/frontier-medicines-announces-exclusive-licensing-agreement-for-fmc-220-a-first-in-class-covalent-p53-y220c-activator-with-lg-chem-ltd/)
- [Frontier Medicines to Present Findings on PI3Kα-RAS Breaker FMC-242 and AI-Powered Frontier™ Platform at AACR Annual Meeting 2026](https://www.frontiermeds.com/press-release/frontier-medicines-to-present-findings-on-pi3kα-ras-breaker-fmc-242-and-ai-powered-frontier-platform-at-aacr-annual-meeting-2026/)
- [Frontier Medicines Announces Publication in Nature Communications Highlighting a Novel Method that Enables Next-Generation Covalent Medicines](https://www.frontiermeds.com/press-release/frontier-medicines-announces-publication-in-nature-communications-highlighting-a-novel-method-that-enables-next-generation-covalent-medicines/)
- [Frontier Medicines to Present at the 44th Annual J.P. Morgan Healthcare Conference](https://www.frontiermeds.com/press-release/frontier-medicines-to-present-at-the-44th-annual-j-p-morgan-healthcare-conference/)
- [J.P. Morgan](https://www.frontiermeds.com/events/jp-morgan/)
- [Frontier Medicines Corporate Presentation](https://www.frontiermeds.com/presentations/events-presentations-placeholder-4/): Frontier Medicines Corporate Presentation
- [Frontier Medicines Presents Preclinical Data from Three Programs at the 37th AACR-NCI-EORTC International Conference on Molecular Targets](https://www.frontiermeds.com/press-release/frontier-medicines-presents-preclinical-data-from-three-programs-at-the-37th-aacr-nci-eortc-international-conference-on-molecular-targets/)
- [Structural basis for DCAF2 as a novel E3 ligase for PROTAC-mediated targeted protein degradation](https://pubmed.ncbi.nlm.nih.gov/41045927/#new_tab)
- [A practical method for determining the rate of covalent modification of fragments and leads](https://pubmed.nc
…
Related sites
Other listed sites in Marketing. See the whole category →
| Domain | Title | Category | Country | Authority | llms.txt | llms-full.txt |
|---|---|---|---|---|---|---|
| hubspot.com | HubSpot | documentation Marketing | 72 | ✓ | ||
| beehiiv.com | beehiiv | interface Marketing | 70 | ✓ | ✓ | |
| sendbird.com | Sendbird | documentation AI and machine learning Developer tools +1 | US | 70 | ✓ | ✓ |
| braze.com | Braze | documentation Marketing | 69 | ✓ | ||
| gumgum.com | GumGum | documentation Marketing | 69 | ✓ | ||
| optimizely.com | Optimizely | documentation Marketing AI agents and MCP | US | 69 | ✓ | |
| semrush.com | Semrush | documentation Marketing | US | 69 | ✓ | |
| siteground.com | SiteGround | documentation AI and machine learning Design +2 | US | 69 | ✓ | ✓ |
Help agents understand your site
Optionally manage your description, publish terms for agents, review file health, measured discovery requests, publisher clicks and score history. Confirm domain control in your browser using a fresh token in your llms.txt, DNS, meta tag or well-known file. No backlink is required.
Manage this listing → · Agent and API instructions
Machine-readable: GET /v1/resolve?q=frontiermeds.com · GET /v1/domain/frontiermeds.com · this page as Accept: application/json or text/markdown · MCP lookup_domain